Assignee
VIVORYON THERAPEUTICS N V
DE·5 granted patents·4 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
9 records- 0180US2025026738A1Crystalline pharmaceutically acceptable salt and polymorphic form of the glutaminyl cyclase inhibitor varoglutamstatVIVORYON THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0278US2026001873A1Novel inhibitorsVIVORYON THERAPEUTICS N V·Filed 2025·Application pending·0 cites
- 0376US12384772B2InhibitorsVIVORYON THERAPEUTICS N V·Filed 2022·Granted Aug 12, 2025·0 cites·7 claims
- 0472US12312335B1Crystalline pharmaceutically acceptable salt and polymorphic form of the glutaminyl cyclase inhibitor VaroglutamstatVIVORYON THERAPEUTICS N V·Filed 2025·Granted May 27, 2025·0 cites·30 claims
- 0572US2025388544A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2025·Application pending·0 cites
- 0666US12378186B2Inhibitors of meprin α and βVIVORYON THERAPEUTICS N V·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 0763US11339152B2InhibitorsVIVORYON THERAPEUTICS N V·Filed 2018·Granted May 24, 2022·0 cites·10 claims
- 0857US2023122243A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2020·Application pending·0 cites
- 0949US12043659B2Humanized and de-immunized antibodiesVIVORYON THERAPEUTICS N V·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when VIVORYON THERAPEUTICS N V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →